期刊
NANO LETTERS
卷 21, 期 1, 页码 693-699出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.nanolett.0c04303
关键词
CRISPR-Cas12a; Metal-enhanced fluorescence (MEF); Cell-free DNA (cfDNA); Colorimetric analysis; Au nanoparticle
类别
资金
- SOL Bio Corporation
- National Research Foundation of Korea [4199990413921] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
A non-nucleic acid amplification fluorescent biosensor using gold nanoparticles for metal-enhanced fluorescence detection of cfDNA has been developed in this study, allowing rapid and highly sensitive detection of BRCA-1. This sensor is highly selective and can be widely applied for the measurement of other nucleic acid biomarkers.
Cell-free DNA (cfDNA) has attracted significant attention due to its high potential to diagnose diseases, such as cancer. Still, its detection by amplification method has limitations because of false-positive signals and difficulty in designing target-specific primers. CRISPR-Cas-based fluorescent biosensors have been developed but also need the amplification step for the detection. In this study, for the first time CRISPR-Cas12a based nucleic acid amplification-free fluorescent biosensor was developed to detect cfDNA by a metal-enhanced fluorescence (MEF) using DNA-functionalized Au nanoparticle (AuNP). Upon activating the CRISPR-Cas12a complex by the target cfDNA and subsequent single-strand DNA (ssDNA) degradation between AuNP and fluorophore, MEF occurred with color changes from purple to red-purple. Using this system, breast cancer gene-1 (BRCA-1) can be detected with very high sensitivity in 30 min. This rapid and highly selective sensor can be applied to measure other nucleic acid biomarkers such as viral DNA in field-deployable and point-of-care testing (POCT) platform.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据